Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
/in Dendritic Cells, International PublicationsAntineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma
/in International Publications, Newcastle Disease VirusDendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
/in Dendritic Cells, International Publications, Multiple MyelomaEngineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
/in Dendritic Cells, International PublicationsImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
/in Checkpoint-Inhibitors, International PublicationsHigh-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial
/in International Publications, MicronutrientsCancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
/in Dendritic Cells, International Publications, Malignant MelanomaHyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data
/in Breast Cancer, Hyperthermia, International PublicationsHyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy
/in Esophageal Carcinoma, Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer